Dr. Dale T Herriott MD

Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

Managing medication and using inhalers have become integral parts of the asthma care routine. An inhaler allows you the freedom of carrying minute doses of medication for use in emergencies wherever you may go. It’s a huge relief knowing that help is immediately at hand in your trouser pocket. Not...

For the first time, two of the world’s largest Cystic Fibrosis (CF) charities, UK’s CF Trust and CF Canada, have joined hands for an international study.They will partner in the Trust’s CLIMB CF study to test the value of using home monitoring devices to track the health status and treatment...

OverviewDyspnea is the clinical term for shortness of breath or breathlessness experienced by both healthy individuals and patients with respiratory or cardiovascular diseases. It can also be a temporary condition that quickly resolves on its own or a symptom of a more serious health condition. A...

Lung cancer is the unsuppressed growth of cells in the tissues of the lungs. Such a condition leads to a tumor (malignant) which may spread (by metastasis) to different organs of the body if not treated in time. Cancer of the lung at the primary stage is also known as carcinoma. The two types of...

Pleurisy is the inflammation of the two membranes that line your lungs. Both your lungs are lined by a thin membrane called the pleura. One layer is lining your lungs and the other is lining the inside of your chest wall. Between these two membranes is a small cavity known as the pleural cavity. It...